Literature DB >> 17657310

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

Chrystal M Paulos1, Claudia Wrzesinski, Andrew Kaiser, Christian S Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A Antony, Steven A Rosenberg, Nicholas P Restifo.   

Abstract

Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8(+) T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8(+) T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand-containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8(+) T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657310      PMCID: PMC1924500          DOI: 10.1172/JCI32205

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

Review 1.  Toll-like receptors and dendritic cells: for whom the bug tolls.

Authors:  Caetano Reis e Sousa
Journal:  Semin Immunol       Date:  2004-02       Impact factor: 11.130

2.  The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

Authors:  W B Coley
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

3.  Symbiont recognition and subsequent morphogenesis as early events in an animal-bacterial mutualism.

Authors:  M J McFall-Ngai; E G Ruby
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

4.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.

Authors:  S E Macatonia; N A Hosken; M Litton; P Vieira; C S Hsieh; J A Culpepper; M Wysocka; G Trinchieri; K M Murphy; A O'Garra
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

5.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

6.  Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

Authors:  Helen Y Wang; Dean A Lee; Guangyong Peng; Zhong Guo; Yanchun Li; Yukiko Kiniwa; Ethan M Shevach; Rong Fu Wang
Journal:  Immunity       Date:  2004-01       Impact factor: 31.745

7.  CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.

Authors:  Natalio Garbi; Bernd Arnold; Siamon Gordon; Günter J Hämmerling; Ruth Ganss
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.

Authors:  Yiping Yang; Ching-Tai Huang; Xiaopei Huang; Drew M Pardoll
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  In vivo survival and homeostatic proliferation of natural killer cells.

Authors:  Martin Prlic; Bruce R Blazar; Michael A Farrar; Stephen C Jameson
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  207 in total

1.  Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation.

Authors:  Zhenyu Yao; Jennifer Jones; Holbrook Kohrt; Samuel Strober
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  Human tumor xenografts: the good, the bad, and the ugly.

Authors:  Richard A Morgan
Journal:  Mol Ther       Date:  2012-05       Impact factor: 11.454

Review 3.  Emerging concepts in haematopoietic cell transplantation.

Authors:  Hao Wei Li; Megan Sykes
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

Review 4.  Therapeutic cancer vaccines: are we there yet?

Authors:  Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.

Authors:  Sid P Kerkar; Pawel Muranski; Andrew Kaiser; Andrea Boni; Luis Sanchez-Perez; Zhiya Yu; Douglas C Palmer; Robert N Reger; Zachary A Borman; Ling Zhang; Richard A Morgan; Luca Gattinoni; Steven A Rosenberg; Giorgio Trinchieri; Nicholas P Restifo
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

6.  Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.

Authors:  Yong Yang; Joy Wolfram; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Small       Date:  2013-12-10       Impact factor: 13.281

Review 7.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 8.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

9.  Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.

Authors:  Joshua D Brody; Matthew J Goldstein; Debra K Czerwinski; Ronald Levy
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

Review 10.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.